Bankwitz et al., 2014 - Google Patents
Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteinsBankwitz et al., 2014
View PDF- Document ID
- 8615708685418397547
- Author
- Bankwitz D
- Vieyres G
- Hueging K
- Bitzegeio J
- Doepke M
- Chhatwal P
- Haid S
- Catanese M
- Zeisel M
- Nicosia A
- Baumert T
- Kaderali L
- Pietschmann T
- Publication year
- Publication venue
- Journal of virology
External Links
Snippet
Hepatitis C virus (HCV) particles associate with lipoproteins and infect cells by using at least four cell entry factors. These factors include scavenger receptor class B type I (SR-BI), CD81, claudin 1 (CLDN1), and occludin (OCLN). Little is known about specific functions of …
- 241000711549 Hepacivirus C 0 title abstract description 137
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay for hepatitis non-A, non-B hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
- C12N2770/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense ssRNA Viruses positive-sense
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bankwitz et al. | Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins | |
| Chang et al. | Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture | |
| Yamamoto et al. | Lipoprotein receptors redundantly participate in entry of hepatitis C virus | |
| Nan et al. | Molecular biology and infection of hepatitis E virus | |
| Yang et al. | Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production | |
| Prentoe et al. | Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus | |
| Prentoe et al. | Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization | |
| Gastaminza et al. | Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion | |
| Xu et al. | Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans | |
| Tanaka et al. | Hallmarks of hepatitis C virus in equine hepacivirus | |
| Fauvelle et al. | Apolipoprotein E mediates evasion from hepatitis C virus neutralizing antibodies | |
| Zhao et al. | Visualizing the essential role of complete virion assembly machinery in efficient hepatitis C virus cell-to-cell transmission by a viral infection-activated split-intein-mediated reporter system | |
| Bankwitz et al. | Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivity | |
| Fan et al. | Attachment and postattachment receptors important for hepatitis C virus infection and cell-to-cell transmission | |
| Fukasawa et al. | Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model | |
| Chen et al. | Polo-like kinase 1 is involved in hepatitis C virus replication by hyperphosphorylating NS5A | |
| Dhillon et al. | Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies | |
| Wu et al. | Reticulon 3 interacts with NS4B of the hepatitis C virus and negatively regulates viral replication by disrupting NS4B self‐interaction | |
| US8846891B2 (en) | Infectious genotype 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a hepatitis C virus lacking the hypervariable region 1 (HVR1) | |
| Mathiesen et al. | Adaptive mutations enhance assembly and cell-to-cell transmission of a high-titer hepatitis C virus genotype 5a core-NS2 JFH1-based recombinant | |
| Carlsen et al. | Characterization of hepatitis C virus recombinants with chimeric E1/E2 envelope proteins and identification of single amino acids in the E2 stem region important for entry | |
| US20110294194A1 (en) | Efficient cell culture system for hepatitis c virus genotype 2b | |
| Haid et al. | Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line | |
| Velázquez-Moctezuma et al. | Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A | |
| Shanmugam et al. | Detergent-resistant membrane association of NS2 and E2 during hepatitis C virus replication |